- Report
- May 2024
- 133 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- April 2024
- 210 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2024
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 193 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2024
- 259 Pages
Global
From €2338EUR$2,450USD£1,959GBP
- Report
- May 2024
- 137 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 135 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- May 2024
- 160 Pages
Global
From €4742EUR$4,969USD£3,973GBP
- Clinical Trials
- April 2024
- 110 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- July 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- February 2025
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2022
- 200 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- August 2022
United States
From €1851EUR$1,940USD£1,551GBP
- Report
- August 2022
Global
From €945EUR$990USD£792GBP

Mesothelioma is a rare form of cancer that affects the lining of the lungs, abdomen, and heart. It is caused by exposure to asbestos and is difficult to treat. Oncology drugs are used to treat mesothelioma, including chemotherapy, radiation therapy, and targeted therapy. Targeted therapy is a newer form of treatment that uses drugs to target specific molecules in cancer cells, which can help slow the growth of the cancer.
The mesothelioma drug market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of mesothelioma, as well as the development of new treatments. Companies in the mesothelioma drug market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. These companies are developing new drugs to treat mesothelioma, as well as providing existing treatments. Show Less Read more